- Home
- FSP vs FATE Comparison
FSP vs FATE Comparison
Compare FSP & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSP
- FATE
- Stock Information
- Founded
- FSP 1981
- FATE 2007
- Country
- FSP United States
- FATE United States
- Employees
- FSP N/A
- FATE N/A
- Industry
- FSP Real Estate Investment Trusts
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSP Real Estate
- FATE Health Care
- Exchange
- FSP Nasdaq
- FATE Nasdaq
- Market Cap
- FSP 159.5M
- FATE 177.7M
- IPO Year
- FSP N/A
- FATE 2013
- Fundamental
- Price
- FSP $1.78
- FATE $1.18
- Analyst Decision
- FSP
- FATE Hold
- Analyst Count
- FSP 0
- FATE 7
- Target Price
- FSP N/A
- FATE $3.83
- AVG Volume (30 Days)
- FSP 471.2K
- FATE 2.2M
- Earning Date
- FSP 07-29-2025
- FATE 08-12-2025
- Dividend Yield
- FSP 2.25%
- FATE N/A
- EPS Growth
- FSP N/A
- FATE N/A
- EPS
- FSP N/A
- FATE N/A
- Revenue
- FSP $115,994,000.00
- FATE $13,335,000.00
- Revenue This Year
- FSP $4.36
- FATE N/A
- Revenue Next Year
- FSP $0.81
- FATE N/A
- P/E Ratio
- FSP N/A
- FATE N/A
- Revenue Growth
- FSP N/A
- FATE 105.85
- 52 Week Low
- FSP $1.36
- FATE $0.66
- 52 Week High
- FSP $2.21
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- FSP 56.00
- FATE 44.34
- Support Level
- FSP $1.67
- FATE $1.02
- Resistance Level
- FSP $1.77
- FATE $1.22
- Average True Range (ATR)
- FSP 0.06
- FATE 0.10
- MACD
- FSP 0.00
- FATE -0.02
- Stochastic Oscillator
- FSP 82.35
- FATE 26.32
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.